# 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

> **NCT00143182** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 504 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00143182
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-07
- **Primary completion:** 2006-06-28
- **Final completion:** 2006-06-28
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143182, "9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00143182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*